Newbridge Financial Services Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.6K | Buy |
+5,500
| New | +$51.6K | 0.01% | 500 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1274 |
|
|
2023
Q3 | – | Sell |
-21
| Closed | -$856 | – | 1374 |
|
|
2023
Q2 | $856 | Hold |
21
| – | – | ﹤0.01% | 1231 |
|
|
2023
Q1 | $783 | Hold |
21
| – | – | ﹤0.01% | 1292 |
|
|
2022
Q4 | $733 | Hold |
21
| – | – | ﹤0.01% | 1327 |
|
|
2022
Q3 | $1K | Sell |
21
-36
| -63% | -$1.71K | ﹤0.01% | 1316 |
|
|
2022
Q2 | $3K | Sell |
57
-719
| -93% | -$37.8K | ﹤0.01% | 1117 |
|
|
2022
Q1 | $56K | Buy |
776
+256
| +49% | +$18.5K | 0.03% | 447 |
|
|
2021
Q4 | $61K | Buy |
520
+484
| +1,344% | +$56.8K | 0.03% | 411 |
|
|
2021
Q3 | $5K | Sell |
36
-24
| -40% | -$3.33K | ﹤0.01% | 1015 |
|
|
2021
Q2 | $10K | Hold |
60
| – | – | 0.01% | 985 |
|
|
2021
Q1 | $5K | Buy |
+60
| New | +$5K | ﹤0.01% | 1033 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1149 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1049 |
|